A vulnerability in DB Manager version 3.0.1.0 and previous and PerformA version 3.0.0.0 and previous allows an authorized user with access to a privileged account on a BD Kiestra system (Kiestra TLA, Kiestra WCA, and InoqulA+ specimen processor) to issue SQL commands, which may result in data corruption.
Conclusion & alert: CVE-2018-10593 is rated Low Risk (34.9/100): CVSS Medium severity, with low exploitation likelihood (EPSS 0.17%). Mandatory action: Monitor for updates and reassess as exploit intelligence or EPSS changes.
Risk is dynamic; we continuously reassess and refresh what is shown on this page as upstream context changes.
EPSS lead: Daily EPSS estimates relative likelihood of exploitation; percentile ranks this CVE among scored vulnerabilities (higher = more severe relative rank).
| # | Date | Old EPSS score | New EPSS score | Delta (New - Old) |
|---|---|---|---|---|
| 1 | 2025-03-19 | 0.08% | 0.17% | +0.09% |
| 2 | 2025-03-17 | 0.04% | 0.08% | +0.04% |
| 3 | 2023-03-07 | — | 0.04% | — |
Full EPSS history (5 records total)
CVSS metrics for this CVE.
| Base score | Version | Severity | Vector | Exploitability | Impact | Score source |
|---|---|---|---|---|---|---|
| 5.6 | 3.0 | MEDIUM |
|
0.4 | 5.2 | [email protected] |
| 3.8 | 2.0 | LOW |
|
4.4 | 4.9 | [email protected] |
| URL | Tags |
|---|---|
| https://ics-cert.us-cert.gov/advisories/ICSMA-18-142-01 | Third Party Advisory US Government Resource |
| https://www.bd.com/en-us/support/product-security-and-privacy/product-security-bulletin-bd-kiestra-tla-bd-kiestra-wca-bd-inoqula | Vendor Advisory |